Akèy › Kansè Poumon ki pa ti selil › Arizona › Scottsdale
Etid klinik pou Kansè Poumon ki pa ti selil nan Scottsdale, AZ
15 etid pou Kansè Poumon ki pa ti selil ap chèche patisipan nan sit nan ak bò kote Scottsdale (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
Ap rekriteFaz 1/2
- HonorHealth Research Institute, Scottsdale
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Ap rekriteFaz 3
- Ironwood Cancer & Research Centers, Scottsdale
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1
- HonorHealth Research Institute, Scottsdale
A Study of KK2269 in Adult Participants With Solid Tumors
Ap rekriteFaz 1
- Mayo Clinic Arizona, Scottsdale
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Ap rekriteFaz 1
- HonorHealth, Scottsdale
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
Ap rekriteFaz 1
- HonorHealth Research Institute, Scottsdale
- Mayo Scottsdale, Scottsdale
A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors
Ap rekriteFaz 1/2
- HonorHealth Research Institute, Scottsdale
AOH1996 for the Treatment of Refractory Solid Tumors
Ap rekriteFaz 1
- Honor Health Research and Innovation Institute, Scottsdale
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Ap rekriteFaz 1
- Mayo Clinic, Scottsdale
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1
- Research Site, Scottsdale
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Ap rekriteFaz 1/2
- Mayo Clinic Scottsdale, Scottsdale
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Scottsdale
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
Ap rekriteFaz 1/2
- HonorHealth Research Institute, Scottsdale
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
Ap rekriteFaz 1/2
- HonorHealth Research Institute, Scottsdale
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Ap rekriteFaz 1
- HonorHealth Research Institute, Scottsdale
Etid Kansè Poumon ki pa ti selil nan lòt vil
- Houston, TX145 etid
- New York City, NY121 etid
- Arlington, VA104 etid
- Nashville, TN97 etid
- Boston, MA90 etid
- Los Angeles, CA87 etid
- St. Louis, MO73 etid
- Chicago, IL61 etid
- Baltimore, MD60 etid
- San Antonio, TX59 etid
- Columbus, OH57 etid
- Washington, DC55 etid
Lòt etid nan Scottsdale
- Kansè nan tete18 etid
- Kansè (tout kalite)18 etid
- Kansè Metastatik17 etid
- Kansè pwostat17 etid
- Kansè kolorektal16 etid
- Kansè pankreyas13 etid
- Melanom10 etid
- Kolit Ulseratif8 etid
- Kansè poumon8 etid
- Kansè fwa (Kasinòm epatoselilè)7 etid
- Maladi Alzheimer7 etid
- Kansè tete negatif triple7 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.